loadpatents
name:-0.059244155883789
name:-0.046350002288818
name:-0.026230096817017
Ashwell; Susan Patent Filings

Ashwell; Susan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ashwell; Susan.The latest application filed is for "inhibiting mutant isocitrate dehydrogenase 1 (midh-1)".

Company Profile
27.42.58
  • Ashwell; Susan - Carlisle MA
  • Ashwell; Susan - Plainsboro NJ
  • Ashwell; Susan - Waltham MA
  • Ashwell; Susan - Lexington MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibiting mutant IDH-1
Grant 11,376,246 - Kelly , et al. July 5, 2
2022-07-05
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
Grant 11,311,527 - Kelly , et al. April 26, 2
2022-04-26
INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
App 20210244727 - ASHWELL; Susan ;   et al.
2021-08-12
Inhibiting Mutant Idh-1
App 20210196701 - Kelly; Patrick F. ;   et al.
2021-07-01
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation
Grant 11,013,734 - Kelly , et al. May 25, 2
2021-05-25
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)
Grant 11,013,733 - Ashwell , et al. May 25, 2
2021-05-25
Treating Patients Harboring An Isocitrate Dehydrogenase 1 (idh-1) Mutation
App 20210085669 - Kelly; Patrick F. ;   et al.
2021-03-25
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20210078973 - Lin; Jian ;   et al.
2021-03-18
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,889,567 - Lin , et al. January 12, 2
2021-01-12
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
Grant 10,807,976 - Lin , et al. October 20, 2
2020-10-20
INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
App 20200297717 - Kelly; Patrick F. ;   et al.
2020-09-24
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20200223822 - Lin; Jian ;   et al.
2020-07-16
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20200115343 - Lin; Jian ;   et al.
2020-04-16
Inhibiting Mutant Idh-1
App 20200108060 - Kelly; Patrick F. ;   et al.
2020-04-09
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,577,329 - Lin , et al.
2020-03-03
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Grant 10,550,099 - Lin , et al. Fe
2020-02-04
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,550,098 - Lin , et al. Fe
2020-02-04
Quinolinone Five-membered Heterocyclic Compounds As Mutant-isocitrate Dehydrogenase Inhibitors
App 20200010464 - Lin; Jian ;   et al.
2020-01-09
INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)
App 20190350921 - Ashwell; Susan
2019-11-21
Inhibiting Mutant Idh-1
App 20190350919 - Kelly; Patrick F. ;   et al.
2019-11-21
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,414,752 - Lin , et al. Sept
2019-09-17
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
Grant 10,407,419 - Lin , et al. Sept
2019-09-10
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190263779 - Lin; Jian ;   et al.
2019-08-29
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190263778 - Lin; Jian ;   et al.
2019-08-29
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190210995 - Lin; Jian ;   et al.
2019-07-11
Phenyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190210970 - Lin; Jian ;   et al.
2019-07-11
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190202790 - Lin; Jian ;   et al.
2019-07-04
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,294,206 - Lin , et al.
2019-05-21
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20190135781 - Lin; Jian ;   et al.
2019-05-09
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Grant 10,280,150 - Lin , et al.
2019-05-07
Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,266,495 - Lin , et al.
2019-04-23
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,253,015 - Lin , et al.
2019-04-09
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180327382 - Lin; Jian ;   et al.
2018-11-15
Phenyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180327361 - Lin; Jian ;   et al.
2018-11-15
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180312487 - Lin; Jian ;   et al.
2018-11-01
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 10,005,734 - Lin , et al. June 26, 2
2018-06-26
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180141910 - Lin; Jian ;   et al.
2018-05-24
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180134682 - Lin; Jian ;   et al.
2018-05-17
Quinolinone Five-membered Heterocyclic Compounds As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180118732 - Lin; Jian ;   et al.
2018-05-03
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20180086733 - Lin; Jian ;   et al.
2018-03-29
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 9,834,539 - Lin , et al. December 5, 2
2017-12-05
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Grant 9,815,817 - Lin , et al. November 14, 2
2017-11-14
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 9,771,349 - Lin , et al. September 26, 2
2017-09-26
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20170174658 - LIN; Jian ;   et al.
2017-06-22
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Grant 9,624,175 - Lin , et al. April 18, 2
2017-04-18
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
Grant 9,624,216 - Lin , et al. April 18, 2
2017-04-18
Fused-bicyclic Aryl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160311774 - Lin; Jian ;   et al.
2016-10-27
Quinolinone Five-membered Heterocyclic Compounds As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160311818 - Lin; Jian ;   et al.
2016-10-27
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160083349 - Lin; Jian ;   et al.
2016-03-24
Pyridinyl Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160083367 - Lin; Jian ;   et al.
2016-03-24
Pyridin-2(1h)-one Quinolinone Derivatives As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160083366 - Lin; Jian ;   et al.
2016-03-24
Quinolinone Pyrimidines Compositions As Mutant-isocitrate Dehydrogenase Inhibitors
App 20160083365 - Lin; Jian ;   et al.
2016-03-24
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 7,973,044 - Konradi , et al. July 5, 2
2011-07-05
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 7,968,547 - Konradi , et al. June 28, 2
2011-06-28
Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
Grant 7,745,454 - Konradi , et al. June 29, 2
2010-06-29
Heteroaryl, Heterocyclic And Aryl Compounds Which Inhibit Leukocyte Adhesion Mediated By Vla-4
App 20100160341 - Konradi; Andrei W. ;   et al.
2010-06-24
Heteroaryl, Heterocyclic And Aryl Compounds Which Inhibit Leukocyte Adhesion Mediated By Vla-4
App 20100160343 - Konradi; Andrei W. ;   et al.
2010-06-24
Substituted Thiophenes And Uses Thereof
App 20090054396 - Ashwell; Susan ;   et al.
2009-02-26
Substitute thiophenes and uses thereof
Grant 7,423,061 - Ashwell , et al. September 9, 2
2008-09-09
3-(heteroaryl)alanine Derivatives-inhibitors Of Leukocyte Adhesion Mediated By Vla-4
App 20080182850 - Konradi; Andrei W. ;   et al.
2008-07-31
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 7,378,529 - Konradi , et al. May 27, 2
2008-05-27
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 7,320,960 - Thorsett , et al. January 22, 2
2008-01-22
Phenylalanine derivatives as alpha 4 integrin inhibitors
Grant 7,291,645 - Konradi , et al. November 6, 2
2007-11-06
Novel fused triazolones and the uses thereof
App 20070149560 - Ashwell; Susan ;   et al.
2007-06-28
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 7,229,970 - Thorsett , et al. June 12, 2
2007-06-12
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
Grant 7,223,762 - Konradi , et al. May 29, 2
2007-05-29
Thiophene derivatives as chk 1 inhibitors
App 20070010556 - Ashwell; Susan ;   et al.
2007-01-11
Substitute thiophenes and uses therof
App 20060281666 - Ashwell; Susan ;   et al.
2006-12-14
Heteroaryl-.beta.-alanine derivatives as alpha 4 integrin inhibitors
Grant 7,015,216 - Konradi , et al. March 21, 2
2006-03-21
Compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20050261293 - Konradi, Andrei W. ;   et al.
2005-11-24
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
Grant 6,953,802 - Konradi , et al. October 11, 2
2005-10-11
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20050222119 - Thorsett, Eugene D. ;   et al.
2005-10-06
Compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 6,949,570 - Ashwell , et al. September 27, 2
2005-09-27
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20050203093 - Konradi, Andrei W. ;   et al.
2005-09-15
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
App 20050192280 - Konradi, Andrei W. ;   et al.
2005-09-01
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 6,911,439 - Konradi , et al. June 28, 2
2005-06-28
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 6,900,179 - Thorsett , et al. May 31, 2
2005-05-31
Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
App 20050085459 - Konradi, Andrei W. ;   et al.
2005-04-21
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
App 20040266763 - Konradi, Andrei W. ;   et al.
2004-12-30
Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4
Grant 6,803,370 - Konradi , et al. October 12, 2
2004-10-12
3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
Grant 6,794,506 - Konradi , et al. September 21, 2
2004-09-21
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20040147512 - Konradi, Andrei W. ;   et al.
2004-07-29
Phenylalanine derivatives as alpha 4 integrin inhibitors
App 20040127486 - Konradi, Andrei W. ;   et al.
2004-07-01
Phenylalanine derivatives as alpha 4 integrin inhibitors
Grant 6,689,781 - Konradi , et al. February 10, 2
2004-02-10
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20040014677 - Thorsett, Eugene D. ;   et al.
2004-01-22
Compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20030144328 - Konradi, Andrei W. ;   et al.
2003-07-31
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated byVLA-4
App 20030139402 - Konradi, Andrei W. ;   et al.
2003-07-24
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20030125324 - Konradi, Andrei W. ;   et al.
2003-07-03
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 6,525,026 - Thorsett , et al. February 25, 2
2003-02-25
Compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20030027850 - Ashwell, Susan ;   et al.
2003-02-06
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20030017993 - Thorsett, Eugene D. ;   et al.
2003-01-23
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
App 20020193312 - Thorsett, Eugene D. ;   et al.
2002-12-19
Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 6,492,421 - Thorsett , et al. December 10, 2
2002-12-10
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 6,492,372 - Konradi , et al. December 10, 2
2002-12-10
Compounds which inhibit leukocyte adhesion mediated by VLA-4
Grant 6,436,904 - Ashwell , et al. August 20, 2
2002-08-20
Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors
App 20020086882 - Konradi, Andrei W. ;   et al.
2002-07-04
Beta-amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4
App 20020058664 - Konradi, Andrei W. ;   et al.
2002-05-16
Phenylalanine derivatives as alpha 4 integrin inhibitors
App 20020055509 - Konradi, Andrei W. ;   et al.
2002-05-09
3-(Heteroaryal) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
App 20020052375 - Konradi, Andrei W. ;   et al.
2002-05-02
Alpha amino acid derivatives--inhibitors of leukocyte adhesion mediated by VLA-4
App 20020052470 - Konradi, Andrei W. ;   et al.
2002-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed